immunocult nk cell base medium Search Results


90
STEMCELL Technologies Inc immunocult nk cell expansion media
Immunocult Nk Cell Expansion Media, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunocult+nk+cell+base+medium/magnetic+beads/pm39127925-193-22-28
Average 90 stars, based on 1 article reviews
immunocult nk cell expansion media - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc immunocult nk cell expansion kit
Design and expression of NK-CARs in peripheral blood <t>NK</t> <t>cells.</t> Left panels indicate schematic representation of NK-CAR designs with different lengths of their ECD; center panels indicate dot plots for NK-CAR cell surface expression in human peripheral blood-activated NK cells 20 h after electroporation. The graph in the right panels indicate the percent CAR positive for the different NK-CAR constructs for ( A ) NKp30-based CAR, ( B ) NKp44-based CAR, and ( C ) NKp46-based CAR. Representative data of three independent experiments using two independent donors are shown. ECD, extracellular domain; SP, signal peptide.
Immunocult Nk Cell Expansion Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/immunocult+nk+cell+base+medium/immunocult+nk+cell+expansion+kit/pmc10835668-49-6-11
Average 90 stars, based on 1 article reviews
immunocult nk cell expansion kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Design and expression of NK-CARs in peripheral blood NK cells. Left panels indicate schematic representation of NK-CAR designs with different lengths of their ECD; center panels indicate dot plots for NK-CAR cell surface expression in human peripheral blood-activated NK cells 20 h after electroporation. The graph in the right panels indicate the percent CAR positive for the different NK-CAR constructs for ( A ) NKp30-based CAR, ( B ) NKp44-based CAR, and ( C ) NKp46-based CAR. Representative data of three independent experiments using two independent donors are shown. ECD, extracellular domain; SP, signal peptide.

Journal: ImmunoHorizons

Article Title: Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells

doi: 10.4049/immunohorizons.2300099

Figure Lengend Snippet: Design and expression of NK-CARs in peripheral blood NK cells. Left panels indicate schematic representation of NK-CAR designs with different lengths of their ECD; center panels indicate dot plots for NK-CAR cell surface expression in human peripheral blood-activated NK cells 20 h after electroporation. The graph in the right panels indicate the percent CAR positive for the different NK-CAR constructs for ( A ) NKp30-based CAR, ( B ) NKp44-based CAR, and ( C ) NKp46-based CAR. Representative data of three independent experiments using two independent donors are shown. ECD, extracellular domain; SP, signal peptide.

Article Snippet: A feeder cell–free method using an ImmunoCult NK cell expansion kit (STEMCELL Technologies) was used to activate isolated NK cells in vitro for 6 d. The isolated NK cells were resuspended in ImmunoCult NK expansion media and seeded on plates coated with ImmunoCult NK cell expansion coating material for 6 d at 37°C in a cell culture incubator.

Techniques: Expressing, Electroporation, Construct

Antitumor activities of NK-CAR constructs. ( A ) Cell surface expression of NK-CARs in human peripheral blood-activated NK cells electroporated with NK-CAR mRNA detected by surface labeling with dye-conjugated recombinant HER2 protein. ( B ) Quantification of flow cytometry plot shown in (A). ( C ) Tumoricidal activity of HER2-targeting NK-CARs. NK cells were cocultured with HER2 + SKOV3 tumor cells at a 5:1 E:T ratio and incubated for 20 h at 37°C. The graph represents the percentage specific killing of SKOV3 cells by NK-CAR–transfected NK cells compared with mock-transfected NK cells. Data are representative of three independent experiments with two donors. The mean ± SD is plotted on the graph, and statistical significance was determined by an ordinary one-way ANOVA with a Dunnett multiple comparison test between mock-transfected NK cells versus NK-CAR cells. The p values are indicated on the graph. ( D ) NK-CARs induce cytokine (TNF-α, IFN-γ, and GM-CSF) and chemokine (CCL2) production when activated by coculturing with SKOV3 tumor cells. The mean ± SD from three replicates is shown. Statistical significance was determined by two-way ANOVA with a Dunnett multiple comparison test between mock and SKOV3 coculture versus NK-CAR and SKOV3 coculture. The p values are indicated on the graph. Data are representative of two independent experiments.

Journal: ImmunoHorizons

Article Title: Chimeric Antigen Cytotoxic Receptors for In Vivo Engineering of Tumor-Targeting NK Cells

doi: 10.4049/immunohorizons.2300099

Figure Lengend Snippet: Antitumor activities of NK-CAR constructs. ( A ) Cell surface expression of NK-CARs in human peripheral blood-activated NK cells electroporated with NK-CAR mRNA detected by surface labeling with dye-conjugated recombinant HER2 protein. ( B ) Quantification of flow cytometry plot shown in (A). ( C ) Tumoricidal activity of HER2-targeting NK-CARs. NK cells were cocultured with HER2 + SKOV3 tumor cells at a 5:1 E:T ratio and incubated for 20 h at 37°C. The graph represents the percentage specific killing of SKOV3 cells by NK-CAR–transfected NK cells compared with mock-transfected NK cells. Data are representative of three independent experiments with two donors. The mean ± SD is plotted on the graph, and statistical significance was determined by an ordinary one-way ANOVA with a Dunnett multiple comparison test between mock-transfected NK cells versus NK-CAR cells. The p values are indicated on the graph. ( D ) NK-CARs induce cytokine (TNF-α, IFN-γ, and GM-CSF) and chemokine (CCL2) production when activated by coculturing with SKOV3 tumor cells. The mean ± SD from three replicates is shown. Statistical significance was determined by two-way ANOVA with a Dunnett multiple comparison test between mock and SKOV3 coculture versus NK-CAR and SKOV3 coculture. The p values are indicated on the graph. Data are representative of two independent experiments.

Article Snippet: A feeder cell–free method using an ImmunoCult NK cell expansion kit (STEMCELL Technologies) was used to activate isolated NK cells in vitro for 6 d. The isolated NK cells were resuspended in ImmunoCult NK expansion media and seeded on plates coated with ImmunoCult NK cell expansion coating material for 6 d at 37°C in a cell culture incubator.

Techniques: Construct, Expressing, Labeling, Recombinant, Flow Cytometry, Activity Assay, Incubation, Transfection, Comparison